Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Typhim Vi vaccine assessment for selective antibody deficiency to polysaccharide
2010-018596-24Phase 4Unknown
- Sponsor
- Oxford University Hospitals
- Start
- Nov 2010
- Modality
- Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Recombinant Protein Vaccines → Recombinant Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label trial of salmonella typhi capsular polysaccharide vaccine in Primary antibody deficiency (PAD) (2 arms), sponsored by Oxford University Hospitals. Status: unknown.
02
Drugs
salmonella typhi capsular polysaccharide vaccine
03
Conditions
Primary antibody deficiency (PAD)
Beyond the preview
Go deeper on 2010-018596-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-018596-24.